AVEO Oncology
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.aveoncology.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About AVEO Oncology
Aveo Oncology is an oncology-focused biopharmaceutical company dedicated to developing innovative medicines aimed at improving the lives of cancer patients. The company is committed to providing effective solutions and is a part of LG Chem. Their product line includes treatments such as FOTIVDA, Ficlatuzumab, and AV-380. Aveo Oncology seeks to partner with healthcare professionals and institutions to advance cancer care.Explore more
Popular SearchesAVEO OncologySIC Code 28,283NAICS Code 32,325Show moreAVEO Oncology Org Chart
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AVEO Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if AVEO Oncology has recently received funding, and reach out quickly before it becomes old news!
Check out if AVEO Oncology is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at AVEO Oncology
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on AVEO Oncology recently announced quarterly report
Product Launch: Get notified when AVEO Oncology launches new products
Click to see if AVEO Oncology had a recent Job posting/layoffs
Funding: Get notified immidiatlly once AVEO Oncology has new funding data
AVEO Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at AVEO Oncology
Find more new buyers
Company Profile Activity
Activity Insights
AVEO Oncology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AVEO Oncology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AVEO Oncology.
AVEO Oncology News & Media
AVEO Oncology, an LG Chem company, Announces Completion of the First Interim Analysis in the Global Phase 3 FIERCE-HN Study
– Global enrollment continues in the Phase 3 registrational study following the planned first interim analysis for patients with HPV- negative recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) – – 20mg/kg dose of ficlatuzumab selected for the combination arm of...AVEO Oncology, an LG Chem company, Announces First Patient Dosed in Front-Line AML Combination Study of Ficlatuzumab
– Collaboration with Blood Cancer United® in its Beat AML® Master Clinical Trial – – AVEO's ficlatuzumab compound to be studied in combination with azacitidine and venetoclax in patients with AML in a Phase 1b/2 clinical trial – – First patient dosed into the Phase 1b/2 clinical trial –...AVEO Oncology, an LG Chem company, and HiberCell Enter Into an Exclusive Development and Option Agreement for First-in-Human Compound
– First-in-Human PERK inhibitor (HC-5404) to be developed in combination with AVEO's FOTIVDA® (tivozanib) for RCC – – AVEO obtains option to an exclusive license for the development, manufacturing, and commercialization of HC-5404 – BOSTON, Nov. 4, 2025 /PRNewswire/ -- AVEO Oncology, an...AVEO Oncology, an LG Chem company, Presents Three Posters at ASCO 2025 Annual Meeting
– TiNivo-2 exploratory subgroup analysis following ICI combination treatments – – AV-380 anti-GDF15 candidate receives generic name Rilogrotug – – Ficlatuzumab and Rilogrotug highlighted in trials in progress posters – BOSTON, June 3, 2025 /PRNewswire/ -- AVEO Oncology, an LG Chem company...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AVEO Oncology
Sign Up For FreeTo access detailed company insights
Aveo Oncology is an oncology-focused biopharmaceutical company dedicated to developing innovative medicines aimed at improving the lives of cancer patients. The company is committed to providing effective solutions and is a part of LG Chem. Their product line includes treatments such as FOTIVDA, Ficlatuzumab, and AV-380. Aveo Oncology seeks to part... Read More
